Efficacy of varenicline or bupropion and its association with nicotine metabolite ratio among smokers with COPD.
Rui QinZhao LiuAn-Qi ChengXin-Mei ZhouZheng SuZi-Yang CuiJin-Xuan LiXiao-Wen WeiLiang ZhaoKian Fan ChungDan XiaoChen WangPublished in: Respirology (Carlton, Vic.) (2024)
Varenicline showed better efficacy than bupropion in normal metabolizers, and bupropion showed equivalent efficacy in slow metabolizers with less side effects. According to our study, NMR provides a better justification for both scientific research and tailoring optimal pharmacotherapy for smoking cessation among smokers in COPD.